EcoDrugPlus

Enhancer Of Zeste 2 Polycomb Repressive Complex 2 Subunit

Ensembl ID : ENSOPRG00000007788
Gene Symbol: EZH2
1 Cross references
222 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 2

Ensembl ID : ENSOPRG00000013342
Gene Symbol: ERBB2
1 Cross references
200 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 3

Ensembl ID : ENSOPRG00000005724
Gene Symbol: ERBB3
1 Cross references
282 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSOPRG00000017282
Gene Symbol: ERBB4
1 Cross references
236 Possible Orthologues:

Estrogen Receptor 1

Ensembl ID : ENSOPRG00000012663
Gene Symbol: ESR1
1 Cross references
210 Possible Orthologues:

Estrogen Receptor 2

Ensembl ID : ENSOPRG00000005700
Gene Symbol: ESR2
1 Cross references
273 Possible Orthologues:

Exportin 1

Ensembl ID : ENSOPRG00000012615
Gene Symbol: XPO1
1 Cross references
304 Possible Orthologues:

Farnesyl Diphosphate Synthase

Ensembl ID : ENSOPRG00000000176
Gene Symbol: FDPS
1 Cross references
265 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSOPRG00000000161
Gene Symbol: FDFT1
1 Cross references
215 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSOPRG00000014922
Gene Symbol: FNTA
1 Cross references
221 Possible Orthologues:

Fatty Acid Amide Hydrolase

Ensembl ID : ENSOPRG00000009871
Gene Symbol: FAAH
1 Cross references
131 Possible Orthologues:

Fibroblast Activation Protein Alpha

Ensembl ID : ENSOPRG00000015724
Gene Symbol: FAP
1 Cross references
127 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).